| # | Drug | Count |
|---|---|---|
| 0 | TEPROTUMUMAB | 3 |
| 1 | RITUXIMAB | 2 |
| 2 | BENDAMUSTINE HCL | 1 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 1 |
| 4 | BISOPROLOL FUMARATE | 1 |
| 5 | METHIMAZOLE | 1 |
| 6 | METHYLPREDNISOLONE | 1 |
| 7 | MYCOPHENOLATE MOFETIL | 1 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 |
| 9 | TOCILIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEPROTUMUMAB | 3 | 0.0005 |
| 1 | METHIMAZOLE | 1 | 0.0001 |
| 2 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 3 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 4 | RITUXIMAB | 2 | 0.0000 |
| 5 | TOCILIZUMAB | 1 | 0.0000 |
| 6 | BISOPROLOL FUMARATE | 1 | 0.0000 |
| 7 | MYCOPHENOLATE MOFETIL | 1 | 0.0000 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 0.0000 |
| 9 | METHYLPREDNISOLONE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 3 | 0.0005 |
| 1 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 4 | Corticosteroid [EPC] | 1 | 0.0000 |